Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

188 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Another Approach, Another Hope?
Koolen J. Koolen J. Cardiovasc Revasc Med. 2020 Sep;21(9):1155-1156. doi: 10.1016/j.carrev.2020.09.042. Cardiovasc Revasc Med. 2020. PMID: 33234237 No abstract available.
Do we need a guide for left main stenting?
Koolen J. Koolen J. Cardiovasc Revasc Med. 2018 Oct;19(7 Pt A):731-732. doi: 10.1016/j.carrev.2018.08.016. Epub 2018 Aug 29. Cardiovasc Revasc Med. 2018. PMID: 30197100 No abstract available.
What Would You Do, Doctor?
Koolen JJ. Koolen JJ. Cardiovasc Revasc Med. 2021 Feb;23:20-21. doi: 10.1016/j.carrev.2020.11.015. Epub 2020 Nov 28. Cardiovasc Revasc Med. 2021. PMID: 33257253 No abstract available.
Randomized Multicenter Trial Investigating Angiographic Outcomes of Hybrid Sirolimus-Eluting Stents With Biodegradable Polymer Compared With Everolimus-Eluting Stents With Durable Polymer in Chronic Total Occlusions: The PRISON IV Trial.
Teeuwen K, van der Schaaf RJ, Adriaenssens T, Koolen JJ, Smits PC, Henriques JP, Vermeersch PH, Tjon Joe Gin RM, Schölzel BE, Kelder JC, Tijssen JG, Agostoni P, Suttorp MJ. Teeuwen K, et al. Among authors: koolen jj. JACC Cardiovasc Interv. 2017 Jan 23;10(2):133-143. doi: 10.1016/j.jcin.2016.10.017. JACC Cardiovasc Interv. 2017. PMID: 28104206 Free article. Clinical Trial.
First Report of Edge Vascular Response at 12 Months of Magmaris, A Second-Generation Drug-Eluting Resorbable Magnesium Scaffold, Assessed by Grayscale Intravascular Ultrasound, Virtual Histology, and Optical Coherence Tomography. A Biosolve-II Trial Sub-Study.
Hideo-Kajita A, Garcia-Garcia HM, Haude M, Joner M, Koolen J, Ince H, Abizaid A, Toelg R, Lemos PA, von Birgelen C, Christiansen EH, Wijns W, Neumann FJ, Kaiser C, Eeckhout E, Teik LS, Escaned J, Azizi V, Kuku KO, Ozaki Y, Dan K, Waksman R. Hideo-Kajita A, et al. Among authors: koolen j. Cardiovasc Revasc Med. 2019 May;20(5):392-398. doi: 10.1016/j.carrev.2019.02.019. Epub 2019 Feb 18. Cardiovasc Revasc Med. 2019. PMID: 31079817 Clinical Trial.
Is It That Difficult to Follow the Instructions?
Koolen JJ. Koolen JJ. Cardiovasc Revasc Med. 2021 Aug;29:7-8. doi: 10.1016/j.carrev.2021.06.015. Epub 2021 Jun 23. Cardiovasc Revasc Med. 2021. PMID: 34172401 No abstract available.
It Was the First Idea, More Than 25 Years Ago….
Koolen J, Breteler J. Koolen J, et al. Cardiovasc Revasc Med. 2022 Oct;43:36-37. doi: 10.1016/j.carrev.2022.07.016. Epub 2022 Jul 27. Cardiovasc Revasc Med. 2022. PMID: 35909033 No abstract available.
Serial in vivo intravascular ultrasound-based echogenicity changes of everolimus-eluting bioresorbable vascular scaffold during the first 12 months after implantation insights from the ABSORB B trial.
Brugaletta S, Gomez-Lara J, Serruys PW, Farooq V, van Geuns RJ, Thuesen L, Dudek D, Koolen J, Chevalier B, McClean D, Windecker S, Smits PC, de Bruyne B, Whitbourn R, Meredith I, van Domburg RT, Sihan K, de Winter S, Veldhof S, Miquel-Hebert K, Rapoza R, Garcia-Garcia HM, Ormiston JA, Bruining N. Brugaletta S, et al. Among authors: koolen j. JACC Cardiovasc Interv. 2011 Dec;4(12):1281-9. doi: 10.1016/j.jcin.2011.08.014. JACC Cardiovasc Interv. 2011. PMID: 22192369 Free article. Clinical Trial.
188 results